EU parliament clears new pharmacovigilance law
This article was originally published in Scrip
Executive Summary
The European Parliament has adopted legislation to strengthen the EU pharmacovigilance framework by establishing mechanisms to better inform patients about adverse drug reactions and allowing direct patient reporting of such adverse events.